ConductScience.org, home

Paper34838239

Blood-based biomarkers for Alzheimer's disease: towards clinical implementation.

Teunissen CE and 8 others. Lancet Neurol, 2022. Cited by 847 papers, by iCite.

Cite this record

ConductScience Library. Blood-based biomarkers for Alzheimer's disease: towards clinical implementation. Papers, record 34838239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34838239

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation.
PubMed
Journal
Lancet Neurol
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
847
iCite
Relative citation ratio, by iCite
77.9
iCite
Revised in PubMed
2022-03-17
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Teunissen CECharlotte E
2Verberk IMWInge M W
3Thijssen EHElisabeth H
4Vermunt LLisa
5Hansson OOskar
6Zetterberg HHenrik
7van der Flier WMWiesje M
8Mielke MMMichelle M
9Del Campo MMarta

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
Amyloid beta-Peptides
Biomarkers
Disease Progression
Humans
tau Proteins

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
U01 AG006786NIA NIH HHSUnited StatesU01AG006786PubMed and NIHNIH RePORTER
P30 AG062677NIA NIH HHSUnited StatesP30AG062677PubMed and NIHNIH RePORTER
U54 AG044170NIA NIH HHSUnited StatesU54AG044170PubMed and NIHNIH RePORTER

Download CSV of grants

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT05604183Hyperspectral Retinal Observations for the Cross-sectional Detection of Alzheimer's DiseaseBackgroundClinicalTrials.gov
NCT07917182Chinese University-Alzheimer's Disease With Vascular and Other Co-pathology: Towards Actionable Neuro-Cognitive-Omic Evaluations (CU-ADVANCE)BackgroundClinicalTrials.gov

Download CSV of trials

Cited by661

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 847 citations.

PMIDTitleJournalYearIn PapersSource
42989187Construction of an auxiliary diagnostic model for Alzheimer's disease based on routine peripheral blood parameters.BMC Psychiatry2026https://conductscience.org/library/papers/42989187PubMed
42967588Chronic kidney disease and blood-based biomarkers of Alzheimer's disease: the brain in kidney disease study.Alzheimers Dement2026https://conductscience.org/library/papers/42967588PubMed
42954299A general practice-centred model for early diagnosis and management of Alzheimer's disease in Denmark: rationale, evidence and a pragmatic diagnostic approach.Scand J Prim Health Care2026https://conductscience.org/library/papers/42954299PubMed
42949229The Target48 Neurodegeneration panel: A novel tool for profiling protein signatures in neurodegenerative disorders.Alzheimers Dement2026https://conductscience.org/library/papers/42949229PubMed
42948155Perspectives on plasma biomarkers for point-of-care diagnostics in Alzheimer's disease: Insights into 2D-BioPAD.J Alzheimers Dis Rep2026https://conductscience.org/library/papers/42948155PubMed
42947286CSF and plasma lipid profiling predicts risk of cognitive impairment in cognitively unimpaired older adults.Alzheimers Dement2026https://conductscience.org/library/papers/42947286PubMed
42947225Short-interval variability and test-retest reliability of Alzheimer's disease plasma biomarkers in a clinically heterogenous cohort.Alzheimers Res Ther2026https://conductscience.org/library/papers/42947225PubMed
42926906Scalable Hydrogel Nanoparticle Enrichment for Enhanced Mass Spectrometry-based Proteomic Analysis of Plasma or Volumetric Dried Blood Samples.Res Sq2026https://conductscience.org/library/papers/42926906PubMed
42913444Blood-Based Biomarkers as Predictors of All-Cause Dementia: A 13-Year Follow-Up in the Whitehall II Cohort Study.Neurology2026https://conductscience.org/library/papers/42913444PubMed
42889489Comparison of brain-derived versus conventional pTau biomarkers in CSF and plasma for detecting Alzheimer's disease.Brain Commun2026https://conductscience.org/library/papers/42889489PubMed
42885984Multimodal Retinal Imaging Correlates With Brain Atrophy and Plasma Biomarkers in Alzheimer's Disease.Transl Vis Sci Technol2026https://conductscience.org/library/papers/42885984PubMed
42883821Plasma Neurofilament Light Chain as a Complementary Biomarker for Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.Int J Mol Sci2026https://conductscience.org/library/papers/42883821PubMed
42877365Feasibility of digital multidomain cognitive testing in mild cognitive impairment and dementia assessment in primary care.J Alzheimers Dis Rep2026https://conductscience.org/library/papers/42877365PubMed
42871474Global research trends and hotspots in blood-based biomarkers for Alzheimer's disease: a bibliometric analysis.Front Aging Neurosci2026https://conductscience.org/library/papers/42871474PubMed
42859768ATRI LIMS: a cloud-native open-source laboratory information management system for biomarker-driven Alzheimer's disease clinical trials.JAMIA Open2026https://conductscience.org/library/papers/42859768PubMed
42855152Plasma p-tau217 as a biomarker for Alzheimer's disease: diagnostic and prognostic value in clinical and population-based studies.Arq Neuropsiquiatr2026https://conductscience.org/library/papers/42855152PubMed
42825863Combined Prognostic Value of Triglyceride-Glucose Index and Bilirubin in Drug-Eluting Stent Restenosis: From Clinical Risk Stratification to Exploratory Vascular-Cell Findings.Cardiovasc Drugs Ther2026https://conductscience.org/library/papers/42825863PubMed
42823889Bayesian networks to estimate prognosis in vascular cognitive impairment and small vessel disease: Integrated analyses of interdependent contributors to multiple outcomes.J Cereb Blood Flow Metab2026https://conductscience.org/library/papers/42823889PubMed
42821845Clinical Factors Associated With Discordant Plasma P-Tau217 and Established Alzheimer Disease Biomarkers.Neurology2026https://conductscience.org/library/papers/42821845PubMed
42818491MRI-derived periventricular diffusivity contextualizes plasma pTau217 associations with Alzheimer pathology: a discovery-validation study.Res Sq2026https://conductscience.org/library/papers/42818491PubMed

See all 661 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
GFAP2670PubTator's text mininghttps://conductscience.org/library/genes/2670NCBI Gene
MAPT4137PubTator's text mininghttps://conductscience.org/library/genes/4137NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34838239

GET https://conductscience.org/api/papers/v1/34838239/cited_by?page=2